Abstract
Introduction
Recent researches on the pathogenesis of chronic obstructive pulmonary disease (COPD) suggest that perturbations in the vasculature may occur early in COPD [1] [2] [3] . Nitric oxide (NO)-mediated, endothelium-dependent relaxation provoked by adenosine diphosphate and acetylcholine is attenuated in the excised pulmonary arteries of patients with COPD compared with those of smoking and non-smoking control subjects [4] . Barr and colleagues demonstrated that impaired flow-mediated dilation, assessed by brachial artery flow-mediated dilation, is associated with low pulmonary function and emphysema in ex-smokers [1] . In this latter study, a linear relationship was demonstrated between flow-mediated dilation and postbronchodilator FEV 1 , and the magnitude of this association was the same in former smokers who had not developed COPD (FEV 1 /FVC ≥ 70%) as in the overall sample (mild to severe COPD). The authors postulated that the systemic nature of endothelial function made likely the alteration of endothelial reactivity in the pulmonary circulation. Based on this assumption, one may hypothesize that endothelial dysfunction of pulmonary arteries would be associated with impaired airway function. Accordingly, Peinado and colleagues showed that maximal relaxation of pulmonary arterial rings induced by acetylcholine is correlated with the FEV 1 /FVC ratio of COPD patients [4] . Inasmuch as endothelial dysfunction is associated with dysregulated nitric oxide (NO) metabolism, we speculated that NO-mediated bronchodilation would also be impaired. We therefore conducted this study to assess whether endothelial dysfunction of pulmonary arteries was associated with modifications of the level of resting tone of isolated airways and their cGMP-mediated dilation. Both parameters are NOdependent, and the former has previously been suggested to be associated with the level of airflow limitation [5] .
Material and Methods

Patients
Consecutive patients referred for lung surgical procedure (lobectomy or pneumonectomy for lung tumour) were eligible. Since impaired flow-mediated systemic dilation has been associated with low pulmonary function in former smokers, only ex-smokers were included (>15 Pack-Year). Based on the post-bronchodilator value of pre-operative pulmonary function test, patients were classified according to GOLD criteria [6] . All patients were informed of these biological experiments (bioethics' law of august 2004). This study was approved by our Institutional Review Board.
Pharmacological studies
Just after resection, segments of pulmonary arteries and bronchi were taken from an area as far as possible from the tumour and were dissected free of parenchyma. Arterial rings were evaluated immediately after dissection, whereas bronchial rings were placed in oxygenated Krebs's solution and stored overnight at 4°C, as previously described [5, 7, 8] .
Intralobar arterial rings (inside diameter of 1.5-2 mm) or bronchial rings (inside diameter 1-2 mm) were suspended on tissue hooks in 5 ml organ baths containing Krebs-Henseleit solution (NaCl, 119 mM; KCl, 5.4 mM; CaCl2, 2.5 mM; KH2PO4, 1.2 mM; MgSO4, 1.2 mM; NaHCO3, 25 mM; glucose, 11.7 mM), gassed with 95% O 2 : 5% CO 2 and maintained at 37°C (pH 7.4). Each preparation was connected to a force displacement transducer (Statham UF-1) and isometric tension changes recorded in a computer (acquisition system: EMKA France, Bourre, France). All conditions were run in duplicate (when the duplicate experiments show discordant values, no result is given). that is based on the upper normal limit of the response in non smokers with normal lung function in our laboratory. accordingly to previous experiments done in an historical group of non smokers. We previously demonstrated that the decrease in vascular reactivity was not due to endothelial damage during manipulations [7] .
Bronchial experiments:
After the initial loading of 2.5 g and subsequent equilibrium period, an initial resting tension (RT1) was obtained, bronchial viability was assessed using 10 -3 M ACh. Then a new resting tension (RT2) was obtained, and a dose response curve to zaprinast (10 -8 to 10 -5 M) was conducted. At the end of the experiment, after an equilibrium period to resting tension, maximal dilation (10 -3 M theophylline) was assessed, as previously described [9] . The absence of epithelial damage has also been checked in preliminary experiments [5] . Results were expressed as raw values (g) or percentage of theophylline-induced relaxation, as specified.
The investigators performing bronchial experiments were blinded for the results of vascular experiments. The Spearman's rank correlation coefficient was used to examine possible correlation between two variables. A P value less than 0.05 was considered as significant.
Statistical analyses
Results
The clinical and functional characteristics of the 20 patients who were included are described in table 1. The characteristics of patients with and without dysfunction were similar. The 
Discussion
Background
It has been shown that an impairment of flow-mediated dilation in systemic circulation occurs early in COPD, and is associated with airflow limitation, independently of smoking history, further suggesting a link between vascular and bronchial functions [1] . We suggest that in former smokers, endothelial dysfunction of pulmonary arteries is associated with impairment of both spontaneous resting tone and cGMP-mediated dilation of airways, establishing a biological link between pulmonary arterial and bronchial functions. To our best knowledge, comparison of arterial and bronchial pharmacological functions obtained from the same lung sample has never been made, and the description of dysfunction of pulmonary arteries has been assessed in a very limited number of studies [4, 10, 11] . A recent pulmonary perspective supported by the National Heart, Lung, and Blood Institute stated that there is a need for methods linking in vitro observations to in vivo disease state with regard to airway smooth muscle function [12] . Along this line we show an inverse relationship between the level of resting tone and FEV 1 , which is consistent with the fact that increased smooth muscle tone may contribute to airflow limitation in COPD, as previously suggested [5, 13, 14] . In our limited series of patients, airflow limitation was similar whether or not endothelial dysfunction was present. Several factors have been shown to contribute to systemic endothelial dysfunction, and our study was not powered to describe clinical and functional factors associated with pulmonary endothelial dysfunction.
Endothelial dysfunction
There is no consensual definition of pulmonary endothelial dysfunction, but we do think that the absence of acetylcholine-induced dilation or even contractile response constitutes a drastic definition. We observed that one quarter of our COPD patients displayed pulmonary endothelial dysfunction, which is in agreement with our subsequent results observed in a larger series [8] . No data are available in the literature for further comparison, but a ~30%
incidence of pulmonary hypertension in COPD patients has been reported [10] . In the study of Peinado and colleagues in mild COPD patients (mean ± SD: 24.9 ± 22.9 %), the dilator response to acetylcholine was diminished as compared to non smokers (40.1 ± 22.0 %), without reaching statistical significance. The standard deviations of their results suggest that some COPD patients depicted a constrictor response to acetylcholine while almost all non smokers have a vasodilator response. Obviously, our results need to be confirmed in a larger sample of patients due to the restricted size of our sample with endothelial dysfunction.
Bronchial dysfunction
The nil to moderate degree of cGMP-mediated bronchial dilation that is evidenced is consistent with the results of other investigators [15] [16] [17] , emphasising the confounding effect of underlying pathology (such as endothelial dysfunction) and the modest contribution of cGMP-mediated dilation in airways. The presence of a systemic endothelial dysfunction suggests an impairment of NO-mediated relaxation in COPD. Our results further argue for a generalized impairment of NO-dependent functions, affecting both vascular and bronchial lung compartments. Airway blood flow reactivity has also been shown to be impaired in exsmokers [18] . Mullershausen and colleagues have demonstrated a similar mechanism of desensitization of NO/cGMP signaling in smooth muscle of both aorta and bronchi of rats, involving phosphodiesterase (PDE) 5 activation [19] , giving insight into the underlying mechanisms of generalized endothelial dysfunction. An increased expression of PDE 5 in models of pulmonary hypertension has been demonstrated [20] . Figure 3 shows that resting tension after ACh was higher in the group with endothelial dysfunction that could already be related to an impaired relaxation after contraction. The bronchial relaxation induced by the nonselective phosphodiesterase (PDE) inhibitor (theophylline) was similar whatever the presence or absence of impaired cGMP-dependent relaxation (see Figure 3) . It first suggests that cAMP-dependent relaxation is preserved whatever the degree of impairment of cGMP-mediated relaxation. In human bronchial smooth muscle, the presence of PDE I, II, III, IV (cAMP specific) and V (cGMP specific) have been identified [16, 21, 22] . One should have expected that theophylline-induced relaxation would be lower in presence of an impairment of cGMP relaxation. Since theophylline, in addition to its PDE inhibitory activity, is an antagonist at adenosine receptors, blockade of adenosine activity has been proposed as a possible mechanism for theophylline's effects. Accordingly, Ethier and Madison have shown that, in addition to its well-established indirect effects on smooth muscle cells, adenosine also has direct effects on contractile signalling pathways since it mobilizes intracellular calcium stores [23] . This may explain why theophylline has a very potent bronchodilating effects ex vivo using a high concentration.
Clinical perspectives
Establishing a formal relationship between pulmonary vascular and bronchial functions is an important issue. We further suggest that NO-related dysfunction may participate in this link.
Whether pulmonary endothelial dysfunction is associated with COPD morbidity warrants further studies. But we recently evidenced a frequent endothelial dysfunction of ex vivo pulmonary arteries of patients suffering from cystic fibrosis (that was associated with pulmonary hypertension), and we further demonstrated that criteria of mild pulmonary vascular disease were evidenced in some patients with cystic fibrosis that participated in exercise limitation [24] .
Finally, it will deserve assessing the effects of statins on bronchial functions because reductions in COPD morbidity and mortality, and improvements in lung function, have been attributed to statin use. Insights into cellular mechanisms indicate that statins promote vasorelaxation partly by upregulating the expression of endothelial NO synthase [25] .
Conclusion
This is the first study suggesting that endothelial dysfunction of pulmonary arteries is associated with increased resting tone and impaired cGMP-mediated dilation of airways in former smokers, suggesting common underlying mechanisms of pulmonary arterial and bronchial dysfunctions. confidence interval. # denotes a P value < 0.05, * denotes a P value < 0.005. Grey circles are patients with endothelial dysfunction (negative acetylcholine-induced dilation = constriction, n=5), whereas white circles are patients without endothelial dysfunction (n=15). 
